
The race to get a Covid-19 vaccine has involved some of the largest vaccine clinical trials ever orchestrated, US Health and Human Services Secretary Alex Azar said Monday.
“Obviously, we’re all hoping that we’ll see data as soon as possible,” Azar said at a conference sponsored by the Milken Institute, a nonpartisan think tank founded by ex-banker Michael Milken.
“It is an amazing achievement for the President, for Operation Warp Speed, for our biopharmaceutical industry in the United States that we even have this in range,” Azar said.
Under Operation Warp Speed, the US is producing millions of vaccines currently. All six vaccine candidates that the US has invested in or contracted to buy are being manufactured at commercial scale right now, Azar said. He said he believes that there will be enough vaccines by the end of December to vaccinate the most vulnerable populations in the US. By the end of January, he believes there will be enough to vaccinate all seniors and health care workers and first responders.
“By the end of March, early April, we believe we will have enough vaccine produced to vaccinate anybody in the United States who wanted to get vaccinated,” Azar said.
The AstraZeneca and Johnson & Johnson vaccine trials are paused in the US, as is Eli Lilly’s monoclonal antibody trial.
“The American people should feel very reassured, actually, by these developments. That shows we’re putting patients at the center,” Azar said. “It shows that we’re playing by the book. It shows that the FDA is in the driver’s seat.”
Vaccine approvals will be determined by the career leadership at the FDA, Azar said.